Showing results (211-220 of 993) with videos related to
Sort By:
Pageof 100
Cancer Chemotherapy and Pharmacology|January 1, 1979
Phase II evaluation of vindesine in the treatment of colorectal and esophageal tumorsA Y Bedikian, M Valdivieso, G P Bodey, et al.Reviews of Infectious Diseases|November 1, 1985
Aztreonam plus vancomycin (plus amikacin) vs. moxalactam plus ticarcillin for the empiric treatment of febrile episodes in neutropenic cancer patientsP Jones, K Rolston, V Fainstein, et al.Oral Surgery, Oral Medicine, and Oral Pathology|December 1, 1986
Quantitative analysis of the oral complications of antileukemia chemotherapyS Dreizen, K B McCredie, G P Bodey, et al.The Journal of Infectious Diseases|November 1, 1983
Effect of broad-spectrum cephalosporins on the microbial flora of recipientsG P Bodey, V Fainstein, I Garcia, et al.American Journal of Clinical Oncology|April 1, 1983
Sequential chemotherapy for adenocarcinoma of unknown primaryA Y Bedikian, G P Bodey, M Valdivieso, et al.Antimicrobial Agents and Chemotherapy|March 1, 1994
Effects of broad-spectrum antibiotics on colonization of gastrointestinal tracts of mice by Candida albicansG Samonis, H Anastassiadou, M Dassiou, et al.Postgraduate Medicine|June 1, 1989
Intertriginous infections in adults receiving antileukemia chemotherapyS Dreizen, K B McCredie, M J Keating, et al.Cancer|November 1, 1989
Spectrum and outcome of microbiologically documented listeria monocytogenes infections in cancer patientsN Khardori, P Berkey, S Hayat, et al.Blood|September 1, 1982
IMVP-16: an effective regimen for patients with lymphoma who have relapsed after initial combination chemotherapyF Cabanillas, F B Hagemeister, G P Bodey, et al.Cancer Treatment Reports|May 1, 1981
Phase II evaluation of methyl-GAG in patients with refractory metastatic breast cancerH Y Yap, G R Blumenschein, F Schell, et al.Pageof 100